key: cord-0785128-jil4df4d authors: Santoro, N.; Cignetti, A.; Tenace, V.; Casonato, I. C.; Cosseddu, D.; Vizzini, M.; De Rosa, G.; Geuna, M. title: Peripheral blood immune status at clinical onset correlates with severity of Coronavirus Disease 2019 date: 2020-06-05 journal: nan DOI: 10.1101/2020.06.03.20116533 sha: 613cc94ce34182f0a55b32c2eacc9f2b3516c44c doc_id: 785128 cord_uid: jil4df4d The Coronavirus Disease 2019 (COVID-19) pandemic is a global threat to healthcare systems, requiring hospitalization in sub intensive and intensive care for respiratory syndrome in 25-30% of patients and accounting for a lethality up to 15%. In this retrospective study the clinical characteristics of 215 COVID-19 patients were correlated with the peripheral blood immune status. Different groups of COVID-19 patients may be identified on the basis of clinical behavior and a strong correlation between groups and age and comorbidities as well as with the immune profile is demonstrated. A lower age correlates with a lower severity of the disease differentiating between patients who may be quarantined at home and those requiring hospitalization. An older age (>82 years) together with a higher number of comorbidities is associated to a very severe prognosis. The absolute number of CD3+, CD4+, CD8+ T lymphocytes was progressively decreasing according to the severity of the disease and a CD3+ and CD8+ threshold indicating very severe cases is suggested. , d p a t i e n t s i s t h e i n c r e a s e d n e u t r o p h i l s c o u n t s , t h e r e d u c e d l y m p h o c y t e s c o u n t s a n d t h e i n c r e a s e d s e r u m l e v e l s o f I L -6 a n d o f C -r e a c t i v e p r o t e i n , s u g g e s t i n g a s t r o n g i n f l a m m a t o r y r e s p o n s e ( 3 ) . A f i r s t r e p o r t o n c h a n g e s i n l y m p h o c y t e p o p u l a t i o n s i n p a t i e n t s s e v e r e l y a f f e c t e d b y C o v i d -1 9 i n d i c a t e a l o w T c e l l s c o u n t , a n i n c r e a s e i n n a ï v e h e l p e r T c e l l s a n d a d e c r e a s e i n m e m o r y h e l p e r T c e l l s ( 4 ) . T h e r e d u c t i o n i n a b s o l u t e c o u n t o f p e r i p h e r a l T c e l l s h a s a l s o b e e n a s s o c i a t e d t o t h e s e v e r i t y o f t h e d i s e a s e ( 5 , 6 ) . T h e a i m o f t h e p r e s e n t s t u d y w a s t o a n a l y z e t h e i m m u n e p r o f i l e o f p e r i p h e r a l b l o o d l y m p h o c y t e s i n p a t i e n t s w i t h C O V I D -1 9 a t h o s p i t a l a d m i s s i o n a n d e v a l u a t e t h e c o r r e l a t i o n b e t w e e n t h e i m m u n e s t a t u s a n d t h e o t h e r c l i n i c a l a n d l a b o r a t o r y p a r a m e t e r s . M a t e r i a l s a n d M e t h o d s . A l l p a t i e n t s ( n = 2 3 0 ) w e r e a d m i t t e d a t e m e r g e n c y d e p a r t m e n t w i t h r e s p i r a t o r y s y m p t o m s c o m p a t i b l e w i t h S A R S -C o V -2 i n f e c t i o n . A l l p a t i e n t s a u t h o r i z e d d a t a d i s c l o s u r e b y s i g n i n g a n . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted June 5, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 5, 2020. . https://doi.org/10.1101/2020.06.03.20116533 doi: medRxiv preprint a n t i b o d i e s u s e d f o r P B , l y s e d w i t h 2 m l o f a m m o n i u m c h l o r i d e s o l u t i o n , c e n t r i f u g e d 5 m i n u t e s a t 4 0 0 g , w a s h e d o n c e w i t h P B S , r e s u s p e n d e d i n 0 , 5 m l o f P B S a n d i m m e d i a t e l y a c q u i r e d t o t h e c y t o m e t e r . T is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 5, 2020. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 5, 2020. T h e l y m p h o c y t e n u m b e r w a s s i g n i f i c a n t l y l o w e r i n t h e S 3 a n d S 5 g r o u p c o m p a r e d t o b o t h S 1 a n d S 2 , w h i l e , c o m p a r i n g t h e v e r y s a m e g r o u p s , t h e g r a n u l o c y t e n u m b e r w a s h i g h e r . T h e s e d a t a s u g g e s t t h a t p a t i e n t s u n d e r g o i n g i n t e n s i v e c a r . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 5, 2020. I n t w o p a t i e n t s , a f t e r t h r e e n e g a t i v e r e s u l t s f o r d e t e c t i o n o f S A R S -C o V -2 R N A b y Q R T -P C R o n s w a b t h r o a t s a m p l e s , a b r o n c h o a l v e o l a r l a v a g e ( B A L ) w i t h d i a g n o s t i c p u r p o s e w a s p e r f o r m e d a n d r e s u l t e d p o s i t i v e . I n b o t h B A L a d i f f e r e n t i a l c o u n t o n c y t o c e n t r i f u g e d c e l l s a n d a f l o w c y t o m e t r is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 5, 2020. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 5, 2020. N e v e r t h e l e s s , w e c a n e s t i m a t e t h a t i n y o u n g e r p a t i e n t s w i t h n o o f f e w c o m o r b i d i t i e s , t h e a b s o l u t e v a l u e o f 3 3 9 x 1 0 6 / L C D 3 + a n d 9 7 x 1 0 6 / L C D 8 + ( b o t h v a l u e s a r e t h e m e a n v a l u e o f S 5 g r o u p ) c o u l d b e s c o r e d a s n e g a t i v e i n d i c a t o r . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 5, 2020. e m e r g e n c i e s / d i s e a s e s / n o v e l -c o r o n a v i r u s -2 0 1 9 / s i t u a t i o n -r e p o r t . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 5, 2020. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 5, 2020. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 5, 2020. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 5, 2020. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted June 5, 2020. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted June 5, 2020. . https://doi.org/10.1101/2020.06.03.20116533 doi: medRxiv preprint . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted June 5, 2020. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity (which was not certified by peer review) Any comorbidity, mean (range) 1,7 (0-8) Treatment Hydroxychloroquine, n (%) Neutrophils/Lymphocytes ratio, mean (range) 7.6 (0.6-97.0)